Merck is passionate about improving health. We are committed to accelerating every step in the journey in our quest to bring treatment options to people with cancer. These clinical trials for breast cancer are investigating different study medications alone, or in combination with other study medications, or standard of care therapy, to see if they can help prevent, find, or treat cancer.
Participating in a clinical trial is an important decision. Anyone participating in a trial should know as much as possible about what is being studied, what risks are involved and what potential benefits may be gained before deciding to enroll. If you are interested in participating in a clinical trial, please talk to your doctor first.
You can also call our clinical trial information center at 1-888-577-8839 to learn more.
|Trial Description||Trial Number||Condition||Phase||Status|
||756||Breast Cancer||Phase 3||Recruiting|
||086||Breast Cancer||Phase 2||Active, not recruiting|
||119||Metastatic Triple Negative Breast Cancer||Phase 3||Active, not recruiting|
||173||Triple Negative Breast Neoplasms||Phase 1||Active, not recruiting|
||355||Triple Negative Breast Cancer (TNBC)||Phase 3||Active, not recruiting|
||522||Triple Negative Breast Neoplasms||Phase 3||Active, not recruiting|
There is a lot to consider when deciding whether to participate in a clinical study. Any clinical study includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.